(Q27021625)

Jakub Hort

series ordinal

2

1 reference

language of work or name

1 reference

October 2012

1 reference

Journal of Cellular and Molecular Medicine

1 October 2012

3 references

25 April 2019

20 August 2019

20 September 2020

3 references

25 April 2019

20 August 2019

16

1 reference

issue

10

1 reference

page(s)

2291-300

1 reference

Creative Commons Attribution 2.5 Generic

copyright license

2 references

Europe PubMed Central

25 April 2019

Europe PubMed Central

on focus list of Wikimedia project

20 August 2019

ScienceSource

0 references

cites work

Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Blood-brain barrier alterations in ageing and dementia

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

21 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Amyloid imaging as a biomarker for cerebral β-amyloidosis and risk prediction for Alzheimer dementia

7 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Resolving controversies on the path to Alzheimer's therapeutics

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Revised and updated recommendations for the establishment of primary stroke centers: a summary statement from the brain attack coalition

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Oxidative stress in Alzheimer disease: a possibility for prevention

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Trans-4-hydroxy-2-hexenal, a product of n-3 fatty acid peroxidation: make some room HNE...

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Systemic tocopherols and F2-isoprostanes and the risk of Alzheimer's disease and dementia: a prospective population-based study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Diagnostic procedures for Parkinson's disease dementia: recommendations from the movement disorder society task force

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

F(2)-isoprostanes as biomarkers of late-onset Alzheimer's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Blood-brain barrier: ageing and microvascular disease--systematic review and meta-analysis

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Elevated levels of 3-nitrotyrosine in brain from subjects with amnestic mild cognitive impairment: implications for the role of nitration in the progression of Alzheimer's disease.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Evidence of increased oxidative damage in subjects with mild cognitive impairment.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Aberrant profiles of native and oxidized glycoproteins in Alzheimer plasma

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Identification of oxidized plasma proteins in Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Biochemical markers related to Alzheimer's dementia in serum and cerebrospinal fluid

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Malondialdehyde, superoxide dismutase, melatonin, iron, copper, and zinc blood concentrations in patients with Alzheimer disease: cross-sectional study

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Oxidative processes in Alzheimer's disease: the role of abeta-metal interactions

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Review: Alzheimer's amyloid beta-peptide-associated free radical oxidative stress and neurotoxicity

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Fatty acid composition of brain phospholipids in aging and in Alzheimer's disease

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Increased levels of DNA breaks in cerebral cortex of Alzheimer's disease patients

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Carbonyl proteins as a clinical marker in Alzheimer's disease and its relation to tryptophan degradation and immune activation.

28 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

The serum protein and lipid oxidation marker levels in Alzheimer's disease and effects of cholinesterase inhibitors and antipsychotic drugs therapy

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Elevated protein-bound levels of the lipid peroxidation product, 4-hydroxy-2-nonenal, in brain from persons with mild cognitive impairment

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Oxidative state in platelets and erythrocytes in aging and Alzheimer's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Elevated levels of oxidative DNA damage in lymphocytes from patients with Alzheimer's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Plasma chain-breaking antioxidants in Alzheimer's disease, vascular dementia and Parkinson's disease.

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Lipid peroxidation and free radical scavengers in Alzheimer's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Plasma concentrations of vitamins A and E and carotenoids in Alzheimer's disease

31 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

EFNS guidelines for the diagnosis and management of Alzheimer's disease.

31 May 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

The use of neuropsychological tests across Europe: the need for a consensus in the use of assessment tools for dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Biomarkers in Alzheimer's disease drug development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Activation of NADPH oxidase in Alzheimer's disease brains.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

In-vivo measurement of activated microglia in dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Oxidative damage is the earliest event in Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Early glycoxidation damage in brains from Down's syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Elevated thiobarbituric acid-reactive substances and antioxidant enzyme activity in the brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Cerebrospinal fluid F2-isoprostane levels are increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Lipid peroxidation is an early event in the brain in amnestic mild cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Formation of isoprostane-like compounds (neuroprostanes) in vivo from docosahexaenoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Determination of malondialdehyde, reduced glutathione levels and APOE4 allele frequency in late-onset Alzheimer's disease in Denizli, Turkey.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Antioxidant defences and oxidative stress markers in erythrocytes and plasma from normally nourished elderly Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Malondialdehyde, carbonyl proteins and albumin-disulphide as useful oxidative markers in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Lipid peroxidation and antioxidant enzyme activities in vascular and Alzheimer dementias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Metalloproteinase's activity and oxidative stress in mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Systemic oxidative stress associated with the neurological diseases of aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Parkinson's disease is associated with oxidative stress: comparison of peripheral antioxidant profiles in living Parkinson's, Alzheimer's and vascular dementia patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Altered plasma antioxidant status in subjects with Alzheimer's disease and vascular dementia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Increased oxidative stress in Alzheimer's disease as assessed with 4-hydroxynonenal but not malondialdehyde

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Nitrosative stress, cellular stress response, and thiol homeostasis in patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Increase of brain oxidative stress in mild cognitive impairment: a possible predictor of Alzheimer disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Plasma F2A isoprostane levels in Alzheimer's and Parkinson's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Peripheral F2-isoprostanes and F4-neuroprostanes are not increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Protein glycation, oxidation and nitration adduct residues and free adducts of cerebrospinal fluid in Alzheimer's disease and link to cognitive impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Peripheral levels of glutathione and protein oxidation as markers in the development of Alzheimer's disease from Mild Cognitive Impairment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Oxidative damage to DNA in lymphocytes from AD patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Detection of oxidative DNA damage in lymphocytes of patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Oxidative DNA damage in peripheral leukocytes of mild cognitive impairment and AD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Remarkable increase in the concentration of 8-hydroxyguanosine in cerebrospinal fluid from patients with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Low plasma vitamin C in Alzheimer patients despite an adequate diet.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Peripheral markers of oxidative stress in probable Alzheimer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Oxidative imbalance in patients with mild cognitive impairment and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Oxidative stress related markers in the "VITA" and the centenarian projects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

The role of free radicals in canine counterpart of senile dementia of the Alzheimer type

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

The lipid peroxidation products as possible markers of Alzheimer's disease in blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Plasma susceptibility to free radical-induced antioxidant consumption and lipid peroxidation is increased in very old subjects with Alzheimer disease.

21 January 2018

2 references

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

21 January 2018

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Increased low-density lipoprotein oxidation, but not total plasma protein oxidation, in Alzheimer's disease

28 November 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Oxidative damage to mitochondrial DNA is increased in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1582-4934.2012.01585.X

Increased lipid peroxidation precedes amyloid plaque formation in an animal model of Alzheimer amyloidosis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Neuronal oxidative stress precedes amyloid-beta deposition in Down syndrome

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Influence of apolipoprotein E genotype on blood redox status of Alzheimer's disease patients.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

RNA oxidation is a prominent feature of vulnerable neurons in Alzheimer's disease.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Imbalances of trace elements related to oxidative damage in Alzheimer's disease brain.

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Brain Regional Correspondence Between Alzheimer's Disease Histopathology and Biomarkers of Protein Oxidation

28 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3823422

Oxidized proteins in Alzheimer's plasma

28 November 2018

1 reference

12 December 2020

Increased 8,12-iso-iPF2alpha-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity

1 reference

12 December 2020

Peripheral antioxidant enzyme activities and selenium in elderly subjects and in dementia of Alzheimer's type--place of the extracellular glutathione peroxidase

1 reference

12 December 2020

Changes of lipofuscin-like pigments in erythrocytes and spleen after whole-body gamma irradiation of rats

1 reference

12 December 2020

No evidence for systemic oxidant stress in Parkinson's or Alzheimer's disease

1 reference

12 December 2020

Ascorbate in healthy subjects, amyotrophic lateral sclerosis and Alzheimer's disease

1 reference

12 December 2020

Cerebrospinal fluid levels of alpha-tocopherol (vitamin E) in Alzheimer's disease

1 reference

12 December 2020

10.1111/J.1582-4934.2012.01585.X

Identifiers

DOI

1 reference

release_f6ur5bjrazbfji2ammcdles6ae

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/f6ur5bjrazbfji2ammcdles6ae

24 November 2022

mapped directly with Wikidata item

1 reference

1 reference

PubMed publication ID

22564475

1 reference